Outcomes of off-label drug uses in hospitals: a multicentric prospective study

por Danés, I., Agustí, A., Vallano, A., Alerany, C., Martínez, J., Bosch, J. A., Ferrer, A., Gratacós, L., Pérez, A., Olmo, M., Marron, S. M. Cano, Valderrama, A., Bonafont, X.
Publicado 2014

Quality of life with first-line pembrolizumab for PD-L1–positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study...

por Van Cutsem, E., Valderrama, A., Bang, Y.-J., Fuchs, C.S., Shitara, K., Janjigian, Y.Y., Qin, S., Larson, T.G., Shankaran, V., Stein, S., Norquist, J.M., Kher, U., Shah, S., Alsina, M.
Publicado 2021